rs760609867
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_007198.4(PLPBP):c.722G>A(p.Arg241Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,612,960 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_007198.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLPBP | NM_007198.4 | c.722G>A | p.Arg241Gln | missense_variant | Exon 8 of 8 | ENST00000328195.8 | NP_009129.1 | |
PLPBP | NM_001349346.2 | c.752G>A | p.Arg251Gln | missense_variant | Exon 8 of 8 | NP_001336275.1 | ||
PLPBP | NM_001349347.2 | c.716G>A | p.Arg239Gln | missense_variant | Exon 8 of 8 | NP_001336276.1 | ||
PLPBP | NM_001349348.2 | c.566G>A | p.Arg189Gln | missense_variant | Exon 8 of 8 | NP_001336277.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000278 AC: 7AN: 251372Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135880
GnomAD4 exome AF: 0.0000322 AC: 47AN: 1460792Hom.: 0 Cov.: 30 AF XY: 0.0000399 AC XY: 29AN XY: 726742
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74326
ClinVar
Submissions by phenotype
Epilepsy, early-onset, vitamin B6-dependent Pathogenic:3
- -
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with epilepsy, early-onset, vitamin B6-dependent (MIM#617290). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from arginine to glutamine. (I) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD (v2) <0.01 for a recessive condition (7 heterozygotes, 0 homozygotes). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0600 - Variant is located in the annotated alanine racemase, N-terminal domain (DECIPHER). (I) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0802 - This variant has moderate previous evidence of pathogenicity in unrelated individuals. This variant has been classified as pathogenic by a clinical laboratory in ClinVar, and has been observed as compound heterozygous in two individuals with vitamin-B6-dependent epilepsy (PMIDs: 27912044, 28391250). (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1002 - This variant has moderate functional evidence supporting abnormal protein function. Transfected and null bacteria demonstrated protein instability, and inability to rescue the mutant phenotype, respectively (PMIDs: 27912044, 28914444). (SP) 1205 - This variant has been shown to be maternally inherited (by Sanger analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
- -
not provided Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 241 of the PROSC protein (p.Arg241Gln). This variant is present in population databases (rs760609867, gnomAD 0.01%). This missense change has been observed in individual(s) with pyridoxine-dependent epilepsy (PMID: 27912044, 28391250, 33728241; external communication). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 374857). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt PROSC protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects PROSC function (PMID: 27912044, 29689137). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at